The 4 analysts offering 1 year price forecasts for PPGN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to PPGN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PPGN EPS for the last quarter is −0.34 CHF despite the estimation of −0.68 CHF. In the next quarter EPS is expected to reach 0.06 CHF. Track more of POLYPEPTIDE N financials and stay on top of what is up with the company.
In the next quarter POLYPEPTIDE N revenue is expected to reach 198.85 M CHF. Check out POLYPEPTIDE N revenue and earnings and make informed decisions.
According to analysts, PPGN price target is 35.47 CHF with a max estimate of 44.70 CHF and a min estimate of 33.22 CHF. Check if this forecast comes true in a year, meanwhile watch POLYPEPTIDE N stock price chart and keep track of the current situation with PPGN news and stock market news.
We've gathered opinions of 5 analysts rating PPGN stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.